drugset / Trial / NCT04667416
Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and preliminary efficacy of PalinGen® Flow for the treatment of chronic ulcers of the lower legs and feet.
Timeline
- Start
- 2021-01-19
- Primary completion
- 2024-03
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PalinGen Flow Amniotic Tissue Allograft | Unknown | — | Subcutaneous |